ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02004522
Brief Title: A Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)

First Submitted : November 13, 2013
First Submitted that Met QC Criteria : December 3, 2013
First Posted : December 9, 2013 (Estimate)

Results First Submitted : October 23, 2018
Results First Submitted that Met QC Criteria : January 4, 2019
Results First Posted : January 8, 2019

Certification/Extension First Submitted : July 30, 2018
Certification/Extension First Submitted that Met QC Criteria : July 30, 2018
Certification/Extension First Posted : August 1, 2018

Last Update Submitted that Met QC Criteria : January 4, 2019
Last Update Posted : January 8, 2019